You are here: Home / Publications / Nontraditional Risk Factors for Cardiovascular Disease and Visceral Adiposity Index among Different Body Size Phenotypes

Nontraditional Risk Factors for Cardiovascular Disease and Visceral Adiposity Index among Different Body Size Phenotypes

Du, Tingting; Zhang, Juan; Yuan, Gang; Zhang, Muxun; Zhou, Xinrong; Liu, Zhaorui; Sun, Xing-xing; & Yu, Xuefeng. (2015). Nontraditional Risk Factors for Cardiovascular Disease and Visceral Adiposity Index among Different Body Size Phenotypes. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 25(1), 100-7. PMCID: PMC4302064

Du, Tingting; Zhang, Juan; Yuan, Gang; Zhang, Muxun; Zhou, Xinrong; Liu, Zhaorui; Sun, Xing-xing; & Yu, Xuefeng. (2015). Nontraditional Risk Factors for Cardiovascular Disease and Visceral Adiposity Index among Different Body Size Phenotypes. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD, 25(1), 100-7. PMCID: PMC4302064

Octet Stream icon 2304.ris — Octet Stream, 2 kB (2,310 bytes)

Background and aims Increased cardiovascular disease and mortality risk in metabolically healthy obese (MHO) individuals remain highly controversial. Several studies suggested risk while others do not. The traditional cardiovascular risk factors may be insufficient to demonstrate the complete range of metabolic abnormalities in MHO individuals. Hence, we aimed to compare the prevalence of elevated lipoprotein (a), apolipoprotein B, and uric acid (UA) levels, apolipoprotein B/apolipoprotein A1 ratio, and visceral adiposity index (VAI) scores, and low apolipoprotein A1 levels among 6 body size phenotypes (normal weight with and without metabolic abnormalities, overweight with and without metabolic abnormalities, and obese with or without metabolic abnormalities). Methods and results We conducted a cross-sectional analysis of 7765 Chinese adults using data from the nationwide China Health and Nutrition Survey 2009. MHO persons had intermediate prevalence of elevated apolipoprotein B and UA levels, apolipoprotein B/apolipoprotein A1 ratio and VAI scores, and low apolipoprotein A1 levels between metabolically healthy normal-weight (MHNW) and metabolically abnormal obese individuals (P < 0.001 for all comparisons). Elevated apolipoprotein B and UA concentrations, apolipoprotein B/apolipoprotein A1 ratio, and VAI scores were all strongly associated with the MHO phenotype (all P < 0.01). Conclusions Prevalence of elevated apolipoprotein B and UA levels, apolipoprotein B/apolipoprotein A1 ratio and VAI scores, and low levels of apolipoprotein A1 was higher among MHO persons than among MHNW individuals. The elevated levels of the nontraditional risk factors and VAI scores in MHO persons could contribute to the increased cardiovascular disease risk observed in long-term studies.




JOUR



Du, Tingting
Zhang, Juan
Yuan, Gang
Zhang, Muxun
Zhou, Xinrong
Liu, Zhaorui
Sun, Xing-xing
Yu, Xuefeng



2015


Nutrition, Metabolism, and Cardiovascular Diseases: NMCD

25

1

100-7








PMC4302064


2304